Vaxcyte (PCVX) Stock Chart & Stock Price History $30.77 +0.22 (+0.72%) Closing price 04:00 PM EasternExtended Trading$30.75 -0.02 (-0.06%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxcyte Stock Price Performance The Vaxcyte (PCVX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 60.77%, with a year-to-date return of -62.41%. In the past month, the stock has decreased 14.22%, reflecting recent market activity. As of the latest close, Vaxcyte traded at $30.55 with a market cap of $3.97 billion and volume of 2.05 million shares. Five years ago, the stock traded at $44.05, representing a 30.15% decrease over that period. At the time, it had a market cap of $2.49 billion and a volume of 171,451 shares. Receive PCVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.71%1 Month Performance-14.22%3 Month Performance-1.94%Year-To-Date Performance-62.41%1 Year Performance-60.77%5 Year Performance-30.15% PCVX Stock Chart for Thursday, August, 28, 2025 PCVX Chart by TradingView Vaxcyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/27/2025$30.25$30.55+0.99%$31.00$29.872.05 million shs$3.97 billion08/26/2025$30.45$30.25-0.66%$30.71$30.011.86 million shs$3.93 billion08/25/2025$32.29$30.45-5.70%$32.32$30.341.87 million shs$3.95 billion08/22/2025$31.91$32.29+1.19%$33.27$31.771.52 million shs$4.19 billion08/21/2025$31.26$31.91+2.08%$32.17$30.691.15 million shs$4.14 billion08/20/2025$31.73$31.26-1.48%$31.92$31.011.15 million shs$4.06 billion08/19/2025$32.09$31.73-1.12%$32.21$31.57948,649 shs$4.12 billion08/18/2025$32.70$32.09-1.87%$33.14$32.051.22 million shs$4.17 billion08/15/2025$31.43$32.70+4.04%$32.83$31.561.15 million shs$4.25 billion08/14/2025$31.55$31.43-0.38%$32.29$30.791.35 million shs$4.08 billion Get the Latest News and Ratings for PCVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter. 08/13/2025$30.00$31.55+5.17%$31.95$30.152.64 million shs$4.10 billion08/12/2025$29.67$30.00+1.11%$30.49$29.812.10 million shs$3.89 billion08/11/2025$29.90$29.67-0.77%$30.44$29.511.65 million shs$3.85 billion08/08/2025$30.01$29.90-0.37%$30.27$29.291.96 million shs$3.86 billion08/07/2025$33.00$30.01-9.06%$31.50$29.082.63 million shs$3.87 billion08/06/2025$33.73$33.00-2.16%$33.42$32.14908,176 shs$4.26 billion08/05/2025$33.72$33.73+0.03%$34.50$33.30919,789 shs$4.35 billion08/04/2025$33.02$33.72+2.12%$33.86$32.55824,499 shs$4.35 billion08/01/2025$33.95$33.02-2.74%$34.44$33.011.11 million shs$4.26 billion07/31/2025$34.82$33.95-2.50%$34.71$33.511.30 million shs$4.38 billion07/30/2025$34.68$34.82+0.40%$36.52$34.50990,221 shs$4.49 billion07/29/2025$35.87$34.68-3.32%$35.93$34.661.09 million shs$4.47 billion07/28/2025$36.63$35.87-2.07%$36.74$35.771.14 million shs$4.63 billion Related Companies Genmab A/S Stock Chart Viatris Stock Chart Dr. Reddy's Laboratories Stock Chart Ascendis Pharma A/S Stock Chart Moderna Stock Chart Qiagen Stock Chart BridgeBio Pharma Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Elanco Animal Health Stock Chart Blueprint Medicines Stock Chart Receive PCVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCVX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access